Understanding How Immunotherapy Works
Lung Cancer
At the moment, only a certain segment of lung cancer patients benefit from immunotherapy. For instance, people with a protein called PD-L1 on their cancer cells respond well to immunotherapy drugs, like Keytruda, that block the protein, thus unleashing the immune system to recognize and attack cancer cells. PD-L1 is just one of dozens of different molecules that play a role in how cancer interacts with and evades the immune system.
Clinical trials are looking at antibodies or blockers for some of the other molecules that will likely expand the number of people with lung cancer who will benefit from immunotherapy.
Learn more about SurvivorNet's rigorous medical review process.
At the moment, only a certain segment of lung cancer patients benefit from immunotherapy. For instance, people with a protein called PD-L1 on their cancer cells respond well to immunotherapy drugs, like Keytruda, that block the protein, thus unleashing the immune system to recognize and attack cancer cells. PD-L1 is just one of dozens of different molecules that play a role in how cancer interacts with and evades the immune system.
Clinical trials are looking at antibodies or blockers for some of the other molecules that will likely expand the number of people with lung cancer who will benefit from immunotherapy.
Learn more about SurvivorNet's rigorous medical review process.
Treatment: Early Stages
Treatment: Stage Three
There are several types of lung cancer surgery, and the decision about which is best is based largely on the location of your cancer, its size and whether it has started to spread.
Treatment: Surgery
There are several types of lung cancer surgery, and the decision about which is best is based largely on the location of your cancer, its size and whether it has started to spread.